FGFR4 provides the conduit to facilitate FGF19 signaling in breast cancer progression

Interrupting the FGF19-FGFR4 axis to therapeutically disrupt cancer progression

(2018) Liwei Lang et al.   CURRENT CANCER DRUG TARGETS

FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib

(2017) Lixia Gao et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Augmentation of the anticancer activity of CYT997 in human prostate cancer by inhibiting Src activity

(2017) Yong Teng et al.   Journal of Hematology & Oncology

Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15

(2017) Mei Zhou et al.   JOURNAL OF HEPATOLOGY

Implications of FGF19 on sorafenib-mediated nitric oxide production in hepatocellular carcinoma cells - a short report

(2017) Lixia Gao et al.   CELLULAR ONCOLOGY

Zbtb38 is a novel target for spinal cord injury

(2017) Yafei Cai et al.   Oncotarget

Increased FGF19 copy number is frequently detected in hepatocellular carcinoma with a complete response after sorafenib treatment

(2016) Masaki Kaibori et al.   Oncotarget

Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival

(2016) Kai Hung Tiong et al.   Oncotarget

Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23

(2015) Chiara Degirolamo et al.   NATURE REVIEWS DRUG DISCOVERY

Mitochondrial ATAD3A combines with GRP78 to regulate the WASF3 metastasis-promoting protein

(2015) Y Teng et al.   ONCOGENE

Frequent methylation of the KLOTHO gene and overexpression of the FGFR4 receptor in invasive ductal carcinoma of the breast

(2015) Ashraf Dallol et al.   TUMOR BIOLOGY

First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway

(2015) M. Hagel et al.   Cancer Discovery

Unique molecular signatures as a hallmark of patients with metastatic breast cancer: Implications for current treatment paradigms

(2015) Jennifer J. Wheler et al.   Oncotarget

Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19

(2014) M. Zhou et al.   CANCER RESEARCH

WASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in breast cancer cells

(2013) Y Teng et al.   ONCOGENE

High fibroblast growth factor 19 (FGF19) expression predicts worse prognosis in invasive ductal carcinoma of breast

(2013) Abdelbaset Buhmeida et al.   TUMOR BIOLOGY

HSP90 and HSP70 Proteins Are Essential for Stabilization and Activation of WASF3 Metastasis-promoting Protein

(2012) Yong Teng et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening

(2011) Eric T. Sawey et al.   CANCER CELL